Home・Stock List・Hims & Hers Health Inc

Hims & Hers Health Inc

Open

SectorConsumer defensive

32.07 4.09

Buy Sell

Overview

Share price change

24h

Current

Min

30.24

Max

31.73

Key metrics
By Trading Economics
Income	-113M -92M
Sales	-9.7M 608M
P/E Sector Avg	57.137 33.699
EPS	-0.19
Profit margin	-15.148
Employees	2,442
EBITDA	-107M -80M

Recommendations
By TipRanks
Recommendations	Buy
12 Months Forecast	-3.05% downside

Dividends
By Acuity
Next Earnings	10 Aug 2026

Market Stats
By TradingEconomics
Market Cap	266M 7B
Previous open	27.98
Previous close	32.07

News Sentiment

By Acuity

50%

52 / 130 Consumer defensive

Hims & Hers Health Inc Chart

Past performance is not a reliable indicator of future results.

Related News

3 Aug 2026, 23:41 UTC

News

Hims & Hers Health shares are higher in after-market trading, following positive growth insights despite facing a lawsuit from the Federal Trade Commission.

31 Jul 2026, 19:36 UTC

Social Media

News

Hims & Hers Health Inc is trading higher amid social media discussions about potential undervaluation, despite facing a lawsuit over user health data practices.

30 Jul 2026, 20:11 UTC

Hims & Hers Health Inc shares are higher today amid high trading volume. Broader economic data showed mixed signals, contributing to market volatility.

29 Jul 2026, 23:16 UTC

Social Media

News

Hims & Hers Health shares declined in after-market trading amid legal challenges from the FTC over alleged privacy violations and a securities fraud investigation.

28 Jul 2026, 23:41 UTC

Hims & Hers Health shares declined in after-market trading, remaining near the lower end of their one-month range amid broader market pressures from Asian tech losses.

27 Jul 2026, 20:03 UTC

News

Social Media

Hims & Hers Health shares rise amid FDA committee's endorsement of peptides, seen as a significant step toward market access for treatments.

24 Jul 2026, 23:16 UTC

Social Media

Hims & Hers Health Inc. shares rose after-hours following positive votes from an FDA/HHS panel on six peptides, with a final decision expected in up to 12 months.

23 Jul 2026, 23:26 UTC

News

Hims & Hers Health Inc shares are higher after an FDA advisory panel recommended easing restrictions on a popular peptide and Canaccord reiterated a Buy rating.

22 Jul 2026, 23:16 UTC

News

Hims & Hers Health shares declined to about $31.66 after mixed options sentiment, with calls outpacing puts amid lighter trading volume.

21 Jul 2026, 17:31 UTC

News

Hims & Hers Health Inc shares are declining amid an investigation into potential wrongdoing and concerns over FDA approval of key peptides.

20 Jul 2026, 18:37 UTC

News

Hims & Hers Health Inc. is trading higher amid broader market dynamics, despite earlier pulling back from a session high.

Peer Comparison

Price change

Hims & Hers Health Inc Forecast

Price Target

By TipRanks

-3.05% downside

12 Months Forecast

Average 29.88 USD -3.05%

High 40 USD

Low 21 USD

Based on 13 Wall Street analysts offering 12 month price targets forHims & Hers Health Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

13 ratings

Buy

Hold

Sell

Based on 13 analysts giving stock ratings to Hims & Hers Health Inc - Dist in the past 3 months.

Sentiment

By Acuity

52 / 130 Consumer defensive

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Hims & Hers Health Inc

Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, sexual health and wellness, skincare, and hair care. In addition, the company's curated non-prescription products include melatonin and biotin in the wellness specialty category; moisturizers, creams, sunscreen, serum, face oil, and face wash in the skincare specialty; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness specialty; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care specialty category. Further, it offers medical consultation and post-consultation support services, as well as health and wellness products through wholesale partners. Hims & Hers Health, Inc. is based in San Francisco, California.